Development of Novel Bioadhesive Buccal Formulation of Diltiazem: In vitro and In vivo Characterization

References

1. 1.↵
   1. Harris D.,
   2. Robinson J. R.

   Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 1992, 81(1),1–10.

   OpenUrlPubMedWeb of Science
2. 2.↵
   1. Nagai T.,
   2. Machida Y.

   Buccal delivery systems using hydrogels. Adv. Drug Del. Rev. 1993, 11(1–2),179–191.

   OpenUrl
3. 3.↵
   1. Anders R.,
   2. Merkle H. P.

   Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int. J. Pharm. 1989, 49 (3),231–240.

   OpenUrl
4. 4.↵
   1. Vishnu Y. V.,
   2. Chandrasekhar K.,
   3. Ramesh G.,
   4. Madhusudan Rao Y.

   Development of mucoadhesive patches for buccal administration of carvedilol. Curr. Drug Del. 2007, 4 (1),27–39.

   OpenUrl
5. 5.↵
   1. Owens T. S.,
   2. Dansereau R. J.,
   3. Sakr A.

   Development and evaluation of extended release bioadhesive sodium fluoride tablets. Int. J. Pharm. 2005, 288 (1),109–122.

   OpenUrlPubMed
6. 6.↵
   1. Jafar A.,
   2. Ali N.,
   3. Djavad F.,
   4. Massoud A.,
   5. Mohammad R. S. S.,
   6. Majid S

   Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers. Farmaco 2004, 59 (2),155–161.

   OpenUrlPubMed
7. 7.↵
   1. Ishida M.,
   2. Nambu N.,
   3. Nagai T.

   Highly viscous gel ointment containing carbopol for application to the oral mucosa. Chem Pharm Bull. (Tokyo) 1983, 31 (12),4561–4564.

   OpenUrlPubMed
8. 8.↵
   1. Braunwatd E.

   Calcium channel blockers. Am J Cardiol. 1980, 46, 1045.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Brittain H. G.

   1. Mazzo D. J.,
   2. Obetz C. L.,
   3. Shuster J.

   Diltiazem Hydrochloride. In Analytical Profiles of Drug Substances and Excipients; Brittain H. G.Ed.; Academic Press: San Diego, CA, 1994; pp 23, 53.

   OpenUrlPubMed
10. 10.↵
    1. Buckley M. M. T.,
    2. Grant S. M.,
    3. Goa K. L.,
    4. McTavish D.,
    5. Sorkin E. M.

    Diltiazem: A reappraisal of its pharmacological properties and therapeutic use. Drugs 1990, 39 (5),757–806.

    OpenUrlPubMedWeb of Science
11. 11.↵
    1. Schurmann W.,
    2. Turner P.

    A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the β-blocking drugs atenolol and propranolol. J. Pharm. Pharmacol. 1978, 30(3), 137–147.

    OpenUrlPubMed
12. 12.↵
    1. Tucker I. G.

    A method to study the kinetics of oral mucosal drug absorption from solutions. J. Pharm. Pharmacol. 1988, 40 (10),679–683.

    OpenUrlPubMed
13. 13.↵
    United States Pharmacopeia 28. National Formulary 23. United States Pharmacopeial Convention; Rockville, MD, 2005; pp 2745.
14. 14.↵
    1. Wong C. F.,
    2. Yuen K. H.,
    3. Peh K. K.

    An in vitro method for buccal adhesion studies: Importance of instrument variables. Int. J. Pharm. 1999, 180 (1), 47–57.

    OpenUrlPubMed
15. 15.↵
    1. Korsmeyer R. W.,
    2. Gurny R.,
    3. Doelker E.,
    4. Buri P.,
    5. Peppas N. A.

    Mechanism of solute release from porous hydro-matrices and other factors may be responsible. Int. J. Pharm. 1983, 15(1), 25–35.

    OpenUrlCrossRefWeb of Science
16. 16.↵
    1. Peppas N. A.

    Analysis of Fickian and non-Fickian drug matrix tablets with respect to the compression force release from polymers. Pharm. Acta Helv. 1985, 60(4) 110–111.

    OpenUrlPubMedWeb of Science
17. 17.↵
    1. Yamsani V. V.,
    2. Gannu R.,
    3. Kolli C. S.,
    4. Bhanoji Rao M. E.,
    5. Yamsani M. R.

    Development and in vitro evaluation of buccoadhesive carvedilol tablets. Acta Pharm. 2007, 57 (2),185–197.

    OpenUrlPubMed
18. 18.↵
    1. Ochs H. R.,
    2. Knuchel M.

    Pharmacokinetics and absolute bioavailability of diltiazem in humans. Klin Wochenschr. 1984, 62 (7),303–306.

    OpenUrlCrossRefPubMed
19. 19.↵
    http://www.rxlist.com/cardizem-la-drug.htm.